Articles with "he4 ca125" as a keyword



Photo from wikipedia

Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?

Sign Up to like & get
recommendations!
Published in 2019 at "Gynecologic oncology"

DOI: 10.1016/j.ygyno.2019.04.006

Abstract: INTRODUCTION Management of a woman with a pelvic mass is complicated by difficulty in discriminating malignant from benign disease. Many serum biomarkers have been examined to determine their sensitivity for detecting malignancy. This study was… read more here.

Keywords: combination; biomarker; he4 ca125; serum ... See more keywords
Photo by walloftheo from unsplash

The combined detection of ovarian cancer biomarkers HE4 and CA125 by a fluorescence and quantum dot dual-signal immunoassay

Sign Up to like & get
recommendations!
Published in 2019 at "Analytical Methods"

DOI: 10.1039/c9ay01454c

Abstract: A novel immunoassay system based on a fluorescence and quantum dot dual-signal for simultaneous detection of HE4 and CA125. read more here.

Keywords: fluorescence quantum; quantum dot; immunoassay; dual signal ... See more keywords
Photo from wikipedia

Value of serum miR-21, HE4 and CA125 in surveillance for postoperative recurrent or metastatic ovarian cancer

Sign Up to like & get
recommendations!
Published in 2022 at "Pakistan Journal of Medical Sciences"

DOI: 10.12669/pjms.38.4.5158

Abstract: Objectives: To study the value of serum miR21, human epididymal secretory protein 4 (HE4) and carbohydrate antigen 125 (CA125) in the surveillance for postoperative recurrent or metastatic ovarian cancer. Methods: A total of 169 patients… read more here.

Keywords: ca125; serum; ovarian cancer; mir he4 ... See more keywords
Photo from wikipedia

Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer

Sign Up to like & get
recommendations!
Published in 2019 at "PLoS ONE"

DOI: 10.1371/journal.pone.0218621

Abstract: Clinical utility of new biomarkers often requires the identification of their optimal threshold. This external validation study was conducted to assess the performance of the preoperative plasma tumor markers HE4 and CA125 optimal cut-offs to… read more here.

Keywords: mortality; ovarian cancer; cancer; he4 ca125 ... See more keywords